{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:12:42Z","timestamp":1791774762206,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s13277-015-3138-3","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T00:16:20Z","timestamp":1422663380000},"page":"4843-4850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Ying-chun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","volume":"15","author":"MJ Duffy","year":"2005","unstructured":"Duffy MJ, Bonfrer JM, Kulpa J, Rustin GJ, Soletormos G, Torre GC, et al. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer. 2005;15:679\u201391. doi: 10.1111\/j.1525-1438.2005.00130.x .","journal-title":"Int J Gynecol Cancer"},{"key":"3138_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1155\/2007\/309382","volume":"23","author":"D Badgwell","year":"2007","unstructured":"Badgwell D, Bast Jr RC. Early detection of ovarian cancer. Dis Markers. 2007;23:397\u2013410.","journal-title":"Dis Markers"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/17530050903266830","volume":"3","author":"DL Meany","year":"2009","unstructured":"Meany DL, Sokoll LJ, Chan DW. Early detection of cancer: immunoassays for plasma tumor markers. Expert Opin Med Diagn. 2009;3:597\u2013605. doi: 10.1517\/17530050903266830 .","journal-title":"Expert Opin Med Diagn"},{"key":"3138_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","volume":"117","author":"FR Ueland","year":"2011","unstructured":"Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, et al. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol. 2011;117:1289\u201397. doi: 10.1097\/AOG.0b013e31821b5118 .","journal-title":"Obstet Gynecol"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1097\/AOG.0b013e31821b1d80","volume":"117","author":"R Ware Miller","year":"2011","unstructured":"Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, et al. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol. 2011;117:1298\u2013306. doi: 10.1097\/AOG.0b013e31821b1d80 .","journal-title":"Obstet Gynecol"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/sj.bjc.6605833","volume":"103","author":"SF Hausler","year":"2010","unstructured":"Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010;103:693\u2013700. doi: 10.1038\/sj.bjc.6605833 .","journal-title":"Br J Cancer"},{"key":"3138_CR8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843\u201354.","journal-title":"Cell"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857\u201366. doi: 10.1038\/nrc1997 .","journal-title":"Nat Rev Cancer"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1\u201312. doi: 10.1016\/j.ydbio.2006.08.028 .","journal-title":"Dev Biol"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1177\/0300060513487652","volume":"41","author":"F Guo","year":"2013","unstructured":"Guo F, Tian J, Lin Y, Jin Y, Wang L, Cui M. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. J Int Med Res. 2013;41:1456\u201361. doi: 10.1177\/0300060513487652 .","journal-title":"J Int Med Res"},{"key":"3138_CR12","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/ijms15034031","volume":"15","author":"WZ Peng","year":"2014","unstructured":"Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191\/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci. 2014;15:4031\u201348. doi: 10.3390\/ijms15034031 .","journal-title":"Int J Mol Sci"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3892\/or.2014.3032","volume":"31","author":"T Li","year":"2014","unstructured":"Li T, Yin J, Yuan L, Wang S, Yang L, Du X, et al. Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival. Oncol Rep. 2014;31:1699\u2013706. doi: 10.3892\/or.2014.3032 .","journal-title":"Oncol Rep"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.ajpath.2012.01.034","volume":"180","author":"P Puerta-Gil","year":"2012","unstructured":"Puerta-Gil P, Garcia-Baquero R, Jia AY, Ocana S, Alvarez-Mugica M, Alvarez-Ossorio JL, et al. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol. 2012;180:1808\u201315. doi: 10.1016\/j.ajpath.2012.01.034 .","journal-title":"Am J Pathol"},{"key":"3138_CR15","doi-asserted-by":"publisher","first-page":"e44398","DOI":"10.1371\/journal.pone.0044398","volume":"7","author":"Q Wang","year":"2012","unstructured":"Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE. 2012;7:e44398. doi: 10.1371\/journal.pone.0044398 .","journal-title":"PLoS ONE"},{"key":"3138_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/mc.21880","volume":"52","author":"T Zhang","year":"2013","unstructured":"Zhang T, Zhao D, Wang Q, Yu X, Cui Y, Guo L, et al. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol Carcinog. 2013;52:581\u201390. doi: 10.1002\/mc.21880 .","journal-title":"Mol Carcinog"},{"key":"3138_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ygyno.2010.09.022","volume":"120","author":"JW Lee","year":"2011","unstructured":"Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, et al. The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol. 2011;120:56\u201362. doi: 10.1016\/j.ygyno.2010.09.022 .","journal-title":"Gynecol Oncol"},{"key":"3138_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/1471-2407-12-627","volume":"12","author":"CW Kan","year":"2012","unstructured":"Kan CW, Hahn MA, Gard GB, Maidens J, Huh JY, Marsh DJ, et al. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer. 2012;12:627. doi: 10.1186\/1471-2407-12-627 .","journal-title":"BMC Cancer"},{"key":"3138_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390. doi: 10.3322\/caac.20107 .","journal-title":"CA Cancer J Clin"},{"key":"3138_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000097943","volume":"70","author":"D Pectasides","year":"2006","unstructured":"Pectasides D, Pectasides E. Maintenance or consolidation therapy in advanced ovarian cancer. Oncology. 2006;70:315\u201324. doi: 10.1159\/000097943 .","journal-title":"Oncology"},{"key":"3138_CR21","doi-asserted-by":"publisher","first-page":"e47003","DOI":"10.1371\/journal.pone.0047003","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, et al. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One. 2012;7:e47003. doi: 10.1371\/journal.pone.0047003 .","journal-title":"PLoS One"},{"key":"3138_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11670-011-0123-2","volume":"23","author":"J Wei","year":"2011","unstructured":"Wei J, Liu LK, Gao W, Zhu CJ, Liu YQ, Cheng T, et al. Reduction of plasma microRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancer. Chin J Cancer Res. 2011;23:123\u20138. doi: 10.1007\/s11670-011-0123-2 .","journal-title":"Chin J Cancer Res"},{"key":"3138_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nbt.2010.02.016","volume":"27","author":"T Saito","year":"2010","unstructured":"Saito T, Saetrom P. MicroRNAs\u2014targeting and target prediction. N Biotechnol. 2010;27:243\u20139. doi: 10.1016\/j.nbt.2010.02.016 .","journal-title":"N Biotechnol"},{"key":"3138_CR24","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.59","volume":"29","author":"ME Peter","year":"2010","unstructured":"Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene. 2010;29:2161\u20134. doi: 10.1038\/onc.2010.59 .","journal-title":"Oncogene"},{"key":"3138_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593\u2013601. doi: 10.1038\/ncb1722 .","journal-title":"Nat Cell Biol"},{"key":"3138_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13\u201321. doi: 10.1016\/j.ygyno.2008.04.033 .","journal-title":"Gynecol Oncol"},{"key":"3138_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ygyno.2012.03.048","volume":"126","author":"JE Dodge","year":"2012","unstructured":"Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, Devries-Aboud M, et al. Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis. Gynecol Oncol. 2012;126:157\u201366. doi: 10.1016\/j.ygyno.2012.03.048 .","journal-title":"Gynecol Oncol"},{"key":"3138_CR28","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","volume":"14","author":"EJ Nam","year":"2008","unstructured":"Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14:2690\u20135. doi: 10.1158\/1078-0432.CCR-07-1731 .","journal-title":"Clin Cancer Res"},{"key":"3138_CR29","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","volume":"67","author":"MV Iorio","year":"2007","unstructured":"Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699\u2013707. doi: 10.1158\/0008-5472.CAN-07-1936 .","journal-title":"Cancer Res"},{"key":"3138_CR30","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","volume":"130","author":"F Meng","year":"2006","unstructured":"Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113\u201329. doi: 10.1053\/j.gastro.2006.02.057 .","journal-title":"Gastroenterology"},{"key":"3138_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CEJ.0b013e328305a07a","volume":"18","author":"W Wu","year":"2009","unstructured":"Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev. 2009;18:50\u20135. doi: 10.1097\/CEJ.0b013e328305a07a .","journal-title":"Eur J Cancer Prev"},{"key":"3138_CR32","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ijc.24071","volume":"124","author":"TK Chung","year":"2009","unstructured":"Chung TK, Cheung TH, Huen NY, Wong KW, Lo KW, Yim SF, et al. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer. 2009;124:1358\u201365. doi: 10.1002\/ijc.24071 .","journal-title":"Int J Cancer"},{"key":"3138_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13277-011-0154-9","volume":"32","author":"F Yaman Agaoglu","year":"2011","unstructured":"Yaman Agaoglu F, Kovancilar M, Dizdar Y, Darendeliler E, Holdenrieder S, Dalay N, et al. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol. 2011;32:583\u20138. doi: 10.1007\/s13277-011-0154-9 .","journal-title":"Tumour Biol"},{"key":"3138_CR34","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513\u20138. doi: 10.1073\/pnas.0804549105 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3138_CR35","doi-asserted-by":"publisher","first-page":"e1003311","DOI":"10.1371\/journal.pgen.1003311","volume":"9","author":"G Leva Di","year":"2013","unstructured":"Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, et al. Estrogen mediated-activation of miR-191\/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 2013;9:e1003311. doi: 10.1371\/journal.pgen.1003311 .","journal-title":"PLoS Genet"},{"key":"3138_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12032-012-0452-0","volume":"30","author":"H Cai","year":"2013","unstructured":"Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013;30:452. doi: 10.1007\/s12032-012-0452-0 .","journal-title":"Med Oncol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3138-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3138-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:11Z","timestamp":1559489351000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3138-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}